I would like to suggest clarification of the information in the "Package
Guidelines" [1] and the "Package Submission" [2] pages.
1. Information that is actually of type "guideline" is (only) stated on the
submission page, which is confusing. Shouldn't one page describe the applied
criteria, and the other the submission procedure?
2. We state: "Packages should also conform to the following: • Use S4 classes
and methods.". This is vague and confusing. I think what it should say is that
*existing* S4 classes and generic functions, and existing methods, should be
re-used. What many developers seem to interpret this as is that they should
come up with lots of their own, new, ideosyncratic S4 classes and methods.
Which mostly only adds overhead and complexity, and rarely any benefit. I would
like to suggest removing that statement, or clarifying it.
Best wishes
Wolfgang
[1] http://www.bioconductor.org/developers/package-guidelines/
[2] http://www.bioconductor.org/developers/package-submission/
_______________________________________________
[email protected] mailing list
https://stat.ethz.ch/mailman/listinfo/bioc-devel